Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie
- Address
- Ul. Macieja Jakubowskiego 2, 30-688 Krakow, Poland
Cardiovascular Diseases
The Department of Cardiology at Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie is conducting research aimed at improving emergency care for patients at risk of acute myocardial infarction. One study investigates how a self‑administered medication can quickly relieve symptoms and reduce the chance of a recurrent heart attack.
- Self‑administered therapy for suspected heart attack
- Rapid‑acting anti‑platelet treatment to prevent recurrent events
The site, located in Cracow, Poland, supports two investigators who focus on advancing cardiovascular care through innovative clinical studies.
Metabolism
Researchers in the cardiology department are also exploring metabolic disorders, specifically evaluating metreleptin as a therapeutic option for individuals with familial partial lipodystrophy. The trial seeks to determine whether regular subcutaneous dosing can improve metabolic balance and quality of life for this rare condition.
- Metreleptin therapy for rare lipodystrophy
- Metabolic regulation and patient outcomes in partial lipodystrophy
Based at the university hospital in Cracow, the program involves two dedicated investigators and reflects the institution’s commitment to addressing both cardiovascular and metabolic health challenges.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Viatris Innovation GmbH1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects with Partial Lipodystrophy | Chiesi Farmaceutici S.p.A. | Phase III | Not Recruiting | Mar 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Hydrocortisone | 1 | Unknown | 2021-01-28 | 2021-01-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.